Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
7.75
-0.20 (-2.52%)
At close: Sep 12, 2025, 3:59 PM
7.75
0.00%
After-hours: Sep 12, 2025, 04:10 PM EDT
Zevra Therapeutics Revenue
Zevra Therapeutics reported an annual revenue of $23.61M, reflecting a -14.02% growth. For the quarter ending June 30, 2025, Zevra Therapeutics generated $25.88M in revenue.
Revenue (ttm)
23.61M
Revenue Growth
-14.02%
Price / Sales Ratio
16.34
Revenue / Employee
400.2K
Employees
59
Market Cap
435.05M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 23.61M | -14.02% |
| Dec 31, 2023 | 27.46M | +170.26% |
| Dec 31, 2022 | 10.16M | -64.53% |
| Dec 31, 2021 | 28.65M | +115.61% |
| Dec 31, 2020 | 13.29M | +3.50% |
| Dec 31, 2019 | 12.84M | +Infinity% |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |